Webinar: AUA Guidelines: Evaluation and Management of Localized Renal Masses: A Case-Based Approach (2020)

August 6, 2020

Course Director: Steven C. Campbell, MD, PhD

This course will be interactive and case-based with imaging and videos that will lead into discussion of the most important AUA Guidelines recommendations. A primary focus will be surgical management and efforts to reduce the risk of complications, manage intraoperative complications, or optimize oncologic and functional outcomes. We will each take 3-5 minutes to highlight one recent major development in the field of kidney cancer.

Acknowledgments:

This educational activity is supported by independent educational grants from:

  • Astellas
  • AstraZeneca
  • Bristol-Myers Squibb
  • Genentech
  • Merck
  • Pfizer, Inc.
  • Sanofi Genzyme

 

Target Audience

  • Urologists
  • Residents
  • Advanced Practice Providers (Nurse Practitioners and Physician Assistants)

Learning Objectives

Upon completion of this activity, the participant will be able to:

  1. Surgically manage challenging kidney cancer cases to prevent complications and optimize functional and oncologic outcomes.
  2. Evaluate, diagnose, and risk stratify patients with localized renal masses.
  3. Counsel patients with localized renal masses about the various management strategies, including oncologic and functional considerations and potential morbidities.
  4. Manage patients with localized renal masses, including appropriate and safe utilization of PN, RN, ablation and active surveillance.
  5. Apply the AUA Guidelines regarding the evaluation and management of localized renal masses safely and effectively and apply recent data about kidney cancer from 2019-2020 to clinical practice.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Course opens: 
06/29/2020
Course expires: 
08/06/2023
Event starts: 
08/06/2020 - 6:00pm EDT
Event ends: 
08/06/2020 - 7:30pm EDT
Part of: 
Summer School Webinar Series (2020)
Add to calendar: 
Rating: 
0

Agenda

Welcome and Introduction

Steven C. Campbell, MD, PhD

Tumor Biology, Evaluation/Diagnosis, including Renal Mass Biopsy

Brian R. Lane, MD, PhD

Counseling, PN and RN, and Functional Outcomes

Steven C. Campbell, MD, PhD

Thermal Ablation and Morbidities of all Strategies

Philip M. Pierorazio, MD

Active Surveillance, Oncologic Outcomes of all Strategies

Robert G. Uzzo MD

Questions and Answers

All Faculty

AUA Guidelines: Evaluation and Management of Localized Renal Masses: A Case-Based Approach (2020) will be held virtually on Thursday, August 6 at 6 PM EST.

***Instructions***

  1. Click the "Register" tab.
  2. If prompted, click “update your profile”. Otherwise, click “Take Course”.
  3. Click “Start” under Live Webinar in the Course Progress pane.
  4. Click "Join Webinar".

Education Council Disclosures

PDF icon Education Council Disclosures 2020

AUA Office of Education Staff has nothing to disclose.

 

Course Director(s)

Steven Campbell, MD, PHD

has no relevant financial relationships to disclose at this time.
Faculty(s)

Brian Lane, MD, PhD, FACS

has no relevant financial relationships to disclose at this time.

Phillip Pierorazio, MD

has a financial relationship (Independent contractor) with Wolters Kluwer;.
has a financial relationship (Independent contractor) with Urogen Pharmaceuticals;.
has a financial relationship (Independent contractor) with Ethicon (J&J);.
has a financial relationship (Independent contractor) with Urogen Pharmaceuticals;.
has a financial relationship (Independent contractor) with Wolters Kluwer;.
has a financial relationship (Independent contractor) with Ethicon (J&J);.

Robert Uzzo, MD

has a financial relationship (Other) with Janssen;.
has a financial relationship (Other) with Janssen;.
has a financial relationship (Other) with Janssen;.

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

AUA Participant Information and Policies

DISCLAIMER:

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:

The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.

REPRODUCTION PERMISSION: 

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

SPECIAL ASSISTANCE/DIETARY NEEDS:

The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Please login or register to take this course.

To join the webinar:

  1. Click on the TAKE COURSE button.
  2. Click “Start” under Live Webinar in the Course Progress pane.
  3. Click "Join Webinar".